ELAN

ELAN

USD

Elanco Animal Health Incorporated Common Stock

$22.500+0.270 (1.215%)

リアルタイム価格

Healthcare
Drug Manufacturers - Specialty & Generic
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$22.230

高値

$22.840

安値

$22.150

出来高

12.80M

企業ファンダメンタルズ

時価総額

11.2B

業種

Drug Manufacturers - Specialty & Generic

United States

取引統計

平均出来高

7.18M

取引所

NYQ

通貨

USD

52週レンジ

安値 $8.02現在値 $22.500高値 $22.96

関連ニュース

PR Newswire

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Elanco Animal Health Incorporated (NYSE: ELAN) today announced label expansions for two of its leading canine prescription parasiticides, Credelio...

もっと見る
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
PR Newswire

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...

もっと見る
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs
Analyst Upgrades

JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24

JP Morgan analyst Chris Schott upgrades Elanco Animal Health from Neutral to Overweight and raises the price target from $18 to $24.

もっと見る
JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24